Patents by Inventor Chenghua Liu
Chenghua Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240363858Abstract: The present application provides a secondary battery, a battery module, a battery pack, and an electrical device. The secondary battery includes a positive electrode plate, a negative electrode plate, and a separator disposed between the positive electrode plate and the negative electrode plate, in which the positive electrode plate comprises a positive electrode coating containing a positive electrode active material comprising a lithium iron phosphate material and a conjugated carbonyl compound. In a discharge process of the secondary battery, in addition to a discharge plateau of the lithium iron phosphate material, a discharge curve further includes a relatively low discharge plateau provided by the conjugated carbonyl compound.Type: ApplicationFiled: July 9, 2024Publication date: October 31, 2024Applicant: CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITEDInventors: Miaomiao DONG, Shaocong OUYANG, Changfeng BIE, Hongyu LIU, Huan NI, Chenghua FU, Xin SUN
-
Patent number: 12095051Abstract: A battery pack includes a first battery cell, a second battery cell, and a third battery cell. A positive electrode active substance of each battery cell is composed of lithium iron phosphate and a low-temperature additive. The low-temperature additive is selected from compounds containing at least two carbonyl groups, which are conjugated with an unsaturated structure or an atom having lone-pair electrons connected with the carbonyl groups, and a discharging cut-off voltage of the battery pack at a low temperature has the following rules: discharging cut-off voltages V1, V2, and V3 of the first battery cell, second battery cell, and third battery cell range from 1.95V to 2.1V, from 1.8 V to 2.0V, from 1.6V to 1.9V, respectively, and V1, V2, and V3 satisfy a relationship of V1>V2>V3.Type: GrantFiled: October 27, 2023Date of Patent: September 17, 2024Assignee: CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITEDInventors: Miaomiao Dong, Shaocong Ouyang, Huan Ni, Hongyu Liu, Changfeng Bie, Xin Sun, Chenghua Fu
-
Publication number: 20240290944Abstract: Provided is a battery pack. The battery pack includes a first battery cell, a second battery cell, and a third battery cell. A positive electrode active substance of each battery cell is composed of lithium iron phosphate and a low-temperature additive. The low-temperature additive is selected from compounds containing at least two carbonyl groups, which are conjugated with an unsaturated structure or an atom having lone-pair electrons connected with the carbonyl groups. At a temperature lower than or equal to 10° C., a ratio of a discharging capacity of a single cell of the second battery cell to a discharging capacity of a single cell of the first battery cell ranges from 1.003 to 1.12, and a ratio of a discharging capacity of a single cell of the third battery cell to a discharging capacity of a single cell of the second battery cell ranges from 1.005 to 1.15.Type: ApplicationFiled: April 28, 2024Publication date: August 29, 2024Inventors: Miaomiao Dong, Changfeng Bie, Shaocong Ouyang, Huan Ni, Hongyu Liu, Xin Sun, Chenghua Fu
-
Publication number: 20240172401Abstract: A chassis for an edge device includes a cabinet and a heat exchange component. The heat exchange component is disposed in a space enclosed by the cabinet. The space in the cabinet is divided into a first space and a second space for placement an electronic device. The heat exchange component performs heat transfer between the first space and the second space. A first air inlet and a first air outlet are disposed in the first space, and an airflow entering from the first air inlet flows through a first surface of the heat exchange component and exits from the first air outlet.Type: ApplicationFiled: January 29, 2024Publication date: May 23, 2024Applicant: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Chenghua Liu, Xiaochu Li, Min Luo, Xiaolong Yan
-
Patent number: 11308062Abstract: An index update method, including: receiving an index update request, where the index update request is used to instruct to create or delete a target index that is associated with a field in a logic table of a tenant; updating metadata information of the logic table in a database in response to the index update request; notifying a coordination service, where the coordination service is used to notify a second data access node to perform a local synchronization update; and after all second data access nodes finish local synchronization updates, performing a data asynchronization update. After the metadata information is updated in the database, an index is updated in two steps. In a first step, a local synchronization update is performed. In a second step, after all data access nodes finish local synchronization updates, a data asynchronization update is performed.Type: GrantFiled: December 18, 2019Date of Patent: April 19, 2022Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Yidong Yang, Chenghua Liu, Yong Deng, Wenqi Zhu, Bingjian Hou
-
Patent number: 11249972Abstract: An index update method, including: receiving an index update request, where the index update request is used to instruct to create or delete a target index that is associated with a field in a logic table of a tenant; updating metadata information of the logic table in a database in response to the index update request; notifying a coordination service, where the coordination service is used to notify a second data access node to perform a local synchronization update; and after all second data access nodes finish local synchronization updates, performing a data asynchronization update. After the metadata information is updated in the database, an index is updated in two steps. In a first step, a local synchronization update is performed. In a second step, after all data access nodes finish local synchronization updates, a data asynchronization update is performed.Type: GrantFiled: December 18, 2019Date of Patent: February 15, 2022Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Yidong Yang, Chenghua Liu, Yong Deng, Wenqi Zhu, Bingjian Hou
-
Publication number: 20200272614Abstract: An index update method, including: receiving an index update request, where the index update request is used to instruct to create or delete a target index that is associated with a field in a logic table of a tenant; updating metadata information of the logic table in a database in response to the index update request; notifying a coordination service, where the coordination service is used to notify a second data access node to perform a local synchronization update; and after all second data access nodes finish local synchronization updates, performing a data asynchronization update. After the metadata information is updated in the database, an index is updated in two steps. In a first step, a local synchronization update is performed. In a second step, after all data access nodes finish local synchronization updates, a data asynchronization update is performed.Type: ApplicationFiled: December 18, 2019Publication date: August 27, 2020Inventors: Yidong Yang, Chenghua Liu, Yong Deng, Wenqi Zhu, Bingjian Hou
-
Publication number: 20200019552Abstract: A query optimization method performed by a data access node includes: receiving a query request that is used to query tenant data; searching for a cached optimal query plan for the query request; if the optimal query plan is found, using the optimal query plan as a target query plan; or if no optimal query plan is found, generating a target query plan corresponding to the query request; and submitting the target query plan to a database, where the target query plan is used by the database to query the tenant data. Logical access (query request) is converted into a query plan (physical data access) by the data access node rather than a database node. In addition, the optimal query plan is used for query, so as to reduce a query cost as much as possible, and improve query performance.Type: ApplicationFiled: September 23, 2019Publication date: January 16, 2020Applicant: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Yong DENG, Chenghua LIU, Yidong YANG, Wenqi ZHU
-
Patent number: 10303691Abstract: Embodiments of the present invention provide a column-oriented database processing method, where a column-oriented database includes a marker column and more than one data column, the data column is used to store specific data in a column store manner, a value of a marker bit of each row in the marker column is used to indicate validity of data that is located in a same row as the marker bit, and the method includes: receiving a query request sent by an application program, where the query request contains a query condition; querying the more than one data column according to the marker column and the query condition to obtain a query result that meets both the query condition and a requirement that a marker bit of the query result in the marker column is valid; and sending the query result to the application program.Type: GrantFiled: June 6, 2016Date of Patent: May 28, 2019Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Jimin Wu, Qing Zhang, Chenghua Liu, Yong Deng
-
Publication number: 20160283558Abstract: Embodiments of the present invention provide a column-oriented database processing method, where a column-oriented database includes a marker column and more than one data column, the data column is used to store specific data in a column store manner, a value of a marker bit of each row in the marker column is used to indicate validity of data that is located in a same row as the marker bit, and the method includes: receiving a query request sent by an application program, where the query request contains a query condition; querying the more than one data column according to the marker column and the query condition to obtain a query result that meets both the query condition and a requirement that a marker bit of the query result in the marker column is valid; and sending the query result to the application program.Type: ApplicationFiled: June 6, 2016Publication date: September 29, 2016Applicant: HUAWEI TECHNOLOGIES CO.,LTD.Inventors: Jimin Wu, Qing Zhang, Chenghua Liu, Yong Deng
-
Publication number: 20110268724Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polypeptides.Type: ApplicationFiled: July 8, 2011Publication date: November 3, 2011Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian-Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Patent number: 7981413Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polypeptides.Type: GrantFiled: August 20, 2008Date of Patent: July 19, 2011Assignee: ARCA Biopharma Inc.Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Patent number: 7678889Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and noncancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.Type: GrantFiled: August 6, 2003Date of Patent: March 16, 2010Assignee: diaDexus, Inc.Inventors: Roberto A. Macina, Susana Salceda, Chenghua Liu, Yongming Sun, Leah R. Turner
-
Publication number: 20090042199Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polypeptides.Type: ApplicationFiled: April 10, 2008Publication date: February 12, 2009Applicant: NUVELO, INC.Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian-Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Publication number: 20090023659Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polypeptides.Type: ApplicationFiled: August 20, 2008Publication date: January 22, 2009Applicant: NUVELO, INC.Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Publication number: 20080260747Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polypeptides.Type: ApplicationFiled: April 10, 2008Publication date: October 23, 2008Applicant: NUVELO, INC.Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian-Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Patent number: 7425610Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted CD84-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from human spleen (Hyseq clone identification numbers 2938352 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted CD84-like polypeptides, and antibodies specific for such polyeptides.Type: GrantFiled: January 25, 2001Date of Patent: September 16, 2008Assignee: Nuvelo, Inc.Inventors: Chiaoyun Kuo, Bryan J. Boyle, Jian-Rui Wang, Y. Tom Tang, Chenghua Liu, Radoje T. Drmanac
-
Patent number: 7361475Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic colon cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating colon cancer and non-cancerous disease states in colon tissue, identifying colon tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered colon tissue for treatment and research.Type: GrantFiled: January 25, 2005Date of Patent: April 22, 2008Assignee: diaDexus, Inc.Inventors: Yongming Sun, Herve E. Recipon, Malavika G. Ghosh, Chenghua Liu
-
Patent number: 7317099Abstract: The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.Type: GrantFiled: December 23, 2000Date of Patent: January 8, 2008Assignee: Kirin Pharma Kabushiki KaishaInventors: Ivan Labat, Y. Tom Tang, Radoje T. Drmanac, Chenghua Liu, Juhi Lee, Nancy K. Mize, John Childs, Cheng-Chi Chao
-
Patent number: 7208267Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.Type: GrantFiled: November 21, 2001Date of Patent: April 24, 2007Assignee: Diadexus, Inc.Inventors: Susana Salceda, Roberto Macina, Herve E. Recipon, Jason Pluta, Yongming Sun, Chenghua Liu